|
Real-time Estimate
Cboe BZX
12:57:01 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 81.15 USD | +0.31% |
|
+3.28% | -6.93% |
| Market Cap | 10.86B 9.75B 9B 8.16B 15.26B 1,032B 15.44B 108B 42.86B 541B 40.77B 39.9B 1,715B | P/E 2026 * |
19.5x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 10.04B 9.01B 8.32B 7.54B 14.1B 954B 14.27B 99.75B 39.61B 500B 37.68B 36.88B 1,585B | EV / Sales 2026 * |
3.14x | EV / Sales 2027 * | 2.85x |
| Free-Float |
85.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| GMED | Delayed | |
CBOE
| GMED | Real-time | |
|
Tradegate
| GM0N | Real-time | |
|
Mexican S.E.
| GMED * | End-of-day quote | |
|
Deutsche Boerse AG
| GM0N | Delayed | |
|
Börse Stuttgart
| GM0N | Delayed | |
|
Boerse Muenchen
| GM0N | Real-time | |
|
Xetra
| GM0N | Delayed |
Last Transcript: Globus Medical, Inc.
| 1 day | +0.28% | ||
| 1 week | +3.28% | ||
| Current month | +8.49% | ||
| 1 month | +8.67% | ||
| 3 months | +0.84% | ||
| 6 months | -10.45% | ||
| Current year | -6.93% |
| 1 week | 78.46 |  | 82.02 |
| 1 month | 72.54 | | 82.02 |
| Current year | 72.54 | | 101.4 |
| 1 year | 59.51 | | 101.4 |
| 3 years | 43.38 | | 101.4 |
| 5 years | 43.38 | | 101.4 |
| 10 years | 19.25 | | 101.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Keith Pfeil
CEO | Chief Executive Officer | 47 | 2025-07-17 |
Kyle Kline
DFI | Director of Finance/CFO | 41 | 2025-07-17 |
Brian Kearns
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Paul
CHM | Chairman | 59 | 2002-12-31 |
David Davidar
BRD | Director/Board Member | 60 | 2002-12-31 |
Daniel Lemaitre
BRD | Director/Board Member | 72 | 2011-04-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 | Exercice | Director | 90,000 | 0.0805% | ||
| 8/18/26 | Exercice | Director | 75,000 | 0.0662% | ||
| 7/27/26 | Don | Founder | -2,500 | 0.0022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.28% | +3.28% | +29.50% | +78.28% | 10.86B | |
| -0.04% | +2.44% | -18.68% | +10.71% | 178B | |
| +0.74% | +1.85% | -19.37% | +15.43% | 116B | |
| +1.18% | +2.02% | +1.80% | +35.64% | 115B | |
| -2.26% | +2.24% | -44.03% | +5.60% | 93.1B | |
| +0.07% | -4.36% | -2.99% | +75.61% | 62.09B | |
| +0.17% | +1.64% | +8.50% | +82.24% | 55.87B | |
| -0.46% | -0.14% | +5.35% | -22.71% | 53.12B | |
| +0.74% | +1.90% | -11.09% | +42.28% | 44.22B | |
| +0.10% | +3.08% | -3.06% | -8.74% | 33.59B | |
| Average | +0.06% | +2.29% | -5.41% | +31.43% | 76.19B | |
| Weighted average by Cap. | +0.04% | +2.37% | -12.03% | +24.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2B 2.87B 2.65B 2.4B 4.49B 304B 4.55B 31.79B 12.62B 159B 12.01B 11.75B 505B | 3.39B 3.05B 2.81B 2.55B 4.77B 322B 4.82B 33.71B 13.39B 169B 12.74B 12.46B 536B |
| Net income | 574M 515M 476M 431M 806M 54.5B 816M 5.7B 2.26B 28.57B 2.15B 2.11B 90.59B | 643M 577M 533M 483M 904M 61.11B 915M 6.39B 2.54B 32.03B 2.42B 2.36B 102B |
| Net Debt | -822M -738M -682M -618M -1.16B -78.11B -1.17B -8.17B -3.25B -40.94B -3.09B -3.02B -130B | -1.2B -1.07B -991M -899M -1.68B -114B -1.7B -11.89B -4.72B -59.56B -4.49B -4.39B -189B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | US$81.26 | +0.44% | 143,866 |
| 26-10-27 | US$80.90 | -1.14% | 634,839 |
| 26-10-26 | US$81.83 | +0.52% | 1,031,159 |
| 26-10-23 | US$81.41 | -0.31% | 768,462 |
| 26-10-22 | US$81.66 | +3.79% | 1,293,941 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GMED Stock
Select your edition
All financial news and data tailored to specific country editions
